Levosimendan for Pulmonary Hypertension and Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to provide continued access to treatment with oral levosimendan (TNX-103) and to describe the safety of continued use of TNX-103 in participants with pulmonary hypertension with heart failure with preserved left ventricular ejection fraction (PH-HFpEF) who received TNX-103 in a parent study.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Open-label extension
Participants receive continued access to oral levosimendan (TNX-103) to assess safety in long-term use
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- TNX-103
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Open-label oral levosimendan 1-3mg
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tenax Therapeutics, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.